Clinical trial
A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal…
NCT00259805 · California Pacific Medical Center Research Institute, Other · Completed
Key facts
| NCT number | NCT00259805 |
|---|---|
| Title | A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis |
| Official title | A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis |
| Lead sponsor | California Pacific Medical Center Research Institute, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Focal Encephalitis, Rasmussen's Encephalitis |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 10 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Dec 1, 2005 |
| Last update posted | Mar 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: